Vesilute Research Peptide

Yes. Every batch of Vesilute is tested by an independent third-party laboratory using HPLC and MS-UPLC, confirming purity and mass identity before the batch is released. Pure Peptides does not test its own material.

It means Vesilute is supplied for in-vitro laboratory research and for no other purpose, and must not be administered to humans or animals. Vesilute is legal to purchase in the United States for in vitro and non-clinical laboratory research. It has no FDA approval and no approved human use. Vesilute is not a scheduled substance under the Controlled Substances Act. Sold strictly for qualified research use, not human or veterinary administration.

Vesilute ships from US stock with cold-chain packaging and full tracking; orders placed before noon EST on business days are typically dispatched the same business day. On arrival, store the lyophilized powder at -20°C or below, dry and protected from light.

Very little. The Vesilute research article lists the searches run on its name and what each returned. A 1999 study tested this dipeptide, Glu-Asp, in mice and in vitro alongside four other dipeptides, and found no difference from its constituent amino acids on immune, phagocytosis or antitoxic measures. A 2015 study found it was one of five soybean peptides that reduced the calcium response to salicin in cells carrying a human bitter taste receptor. One physical chemistry paper has measured calcium binding to this dipeptide, and the result was unremarkable. Other peptides in the same series have their own literature. The trade name appears in two indexed papers from that program: a 2016 docking study that lists it with no activity label, and a 2022 review that gives it a computed docking score and a bladder label that cites no source. The bladder attribution itself goes back at least to the program's own patent filing, which has not been peer reviewed.